Hypertension in Patients with Insulin Resistance: Etiopathogenesis and Management in Children

Veronica Maria Tagi1, Francesca Mainieri1, Francesco Chiarelli1

  • 1Department of Pediatrics, University of Chieti, Via dei Vestini 5, 66100 Chieti, Italy.

Insights

Insulin resistance (IR) contributes to hypertension (HS) in diabetes mellitus (DM) patients. This review highlights IR

Area of Science:

  • Endocrinology
  • Cardiology
  • Pediatrics

Background:

  • Insulin resistance (IR) is a significant factor in the development of hypertension (HS) among individuals with diabetes mellitus (DM).
  • Recent literature indicates multiple complex pathways linking IR to HS.
  • Specific management of HS is crucial for pediatric patients with DM.

Purpose of the Study:

  • To elucidate the pathophysiological mechanisms by which IR contributes to HS.
  • To outline the specialized treatment principles for HS in children with DM.

Main Methods:

  • Literature review of recent studies on IR, HS, and DM.
  • Analysis of current European Society of HS and American Academy of Pediatrics guidelines.

Main Results:

  • IR influences HS through various interconnected biological pathways.
  • Current guidelines emphasize tailored HS treatment strategies for diabetic children.

Conclusions:

  • Understanding the IR-HS link is vital for managing hypertension in diabetic children.
  • Adherence to updated guidelines ensures optimal HS treatment for this vulnerable population.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
99
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
94
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
417
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K